Reza Lillian, Bapir Lara, Iqbal Nusrat, Sackitey Charlene, Hughes Sally, Babbar Mina, Marinova Rali, Marinova Petya, Avery Pearl, Lung Phillip, Segal Jonathan P, Myrelid Pär, Gionchetti Paolo, Verstockt Bram, Hart Ailsa, Clark Sue K, Tozer Phil
Robin Phillips Fistula Research Unit, St Mark's Hospital, Imperial College London, London, UK.
West Middlesex University Hospital, Isleworth, UK.
Colorectal Dis. 2025 Aug;27(8):e70184. doi: 10.1111/codi.70184.
The primary aim was to develop a patient-centred core outcome set (COS) for interventional studies in patients with pouch anal and vaginal fistula (PAVF).
PAVFCOS was developed using the methodology outlined by the Core Outcome Measures in Effectiveness Trials (COMET). Systematic review and qualitative patient interviews produced a long list of candidate outcomes. An online Delphi exercise was conducted with stakeholders to prioritise and shortlist outcomes. A consensus meeting of patients and clinicians ratified the final core outcome set.
A systematic review of the literature and 14 qualitative patient interviews produced a long list of 99 outcomes. These were reduced to 46 outcomes and subjected to two rounds of a Delphi exercise with 70 participants, including patients (45%), colorectal surgeons (31%), radiologists (6%), gastroenterologists (11%) and pouch specialist nurses (7%). Thirty-six outcomes were discussed in a consensus meeting of seven clinicians and seven patients. Seven core outcomes were selected for inclusion: global assessment of continence, pain related to fistula and surrounding area, impact on quality of life of fistula discharge, fistula healing (clinical and radiological), new fistula or abscess, need for rescue intervention (minor or major) and global quality-of-life assessment.
PAVFCOS is the first to establish outcomes that are important to patients with pouch anal and vaginal fistula. PAVFCOS should be used in interventional studies to introduce much-needed standardisation of outcome reporting in this challenging condition.
主要目的是为贮袋肛管和阴道瘘(PAVF)患者的介入研究制定以患者为中心的核心结局集(COS)。
采用有效性试验核心结局指标(COMET)概述的方法制定PAVFCOS。系统评价和患者定性访谈产生了一长串候选结局。与利益相关者进行了在线德尔菲调查,以对结局进行优先排序并筛选入围结局。患者和临床医生的共识会议批准了最终的核心结局集。
对文献进行系统评价并进行14次患者定性访谈后,产生了包含99项结局的一长串清单。这些结局被缩减至46项,并对70名参与者进行了两轮德尔菲调查,参与者包括患者(45%)、结直肠外科医生(31%)、放射科医生(6%)、胃肠病学家(11%)和贮袋专科护士(7%)。在由7名临床医生和7名患者参加的共识会议上讨论了36项结局。选择纳入7项核心结局:控便的整体评估、与瘘管及周围区域相关的疼痛、瘘管排出物对生活质量的影响、瘘管愈合(临床和影像学)、新的瘘管或脓肿、是否需要挽救性干预(轻微或重大)以及生活质量的整体评估。
PAVFCOS是首个确立对贮袋肛管和阴道瘘患者重要的结局的核心结局集。PAVFCOS应用于介入研究,以便在这种具有挑战性的情况下引入急需的结局报告标准化。